The EXTAJECT brand, founded in 2008 (Switzerland), from 2951 sister brands and 17477 competing brands. EXTAJECT is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. The sector of EXTAJECT is Drug Manufacturers.
Investment simulator :
Portfolio valuation
NOVARTIS N
(EXTAJECT)
over 5 years*
CHF 100.35